In lung cancer studies, the expression of CD31, CD34, and CD105 was found to be closely related to the type of tissue, differing significantly between cancerous tissues, pre-cancerous tissues, and healthy tissues adjacent to tumors, indicating their potential as indicators of tumor malignancy (23, 25). This evidence concerns the gene PECAM1 and lung cancer.